Stock Region Watchlist
🎬 The Media Drama Continues: WBD & Paramount Skydance.
The Media Giants Are Talking Again (Plus a $9.9B Deal!) 🎥💉
The stocks featured in this report were previously delivered in our trading room in real-time. To access Stock Region’s real-time trade ideas, then be sure to purchase a membership now.
Disclaimer: The following content is for informational and entertainment purposes only and does not constitute financial advice. This is not financial advice. All investment strategies and investments involve risk of loss. Nothing contained in this newsletter should be construed as investment advice. Please do your own research or consult a licensed professional before making any investment decisions.
Happy Tuesday, Stock Region family!
This week brings a distinct buzz in the air—a signal that the market is offering something juicy right out of the gate. February 17, 2026, delivers a news cycle packed with excitement: media giants shaking up the industry landscape once again and a massive billion-dollar deal in the healthcare sector.
Pour a fresh cup of coffee, settle in, and take a look at what’s moving the markets today.
🎬 The Media Drama Continues: WBD & Paramount Skydance
Just when it seemed that the dust had settled, the drama returns. The situation is unfolding like a classic TV show cliffhanger, keeping everyone on the edge of their seats.
Warner Bros. Discovery ($WBD)
The Scoop: Back in December, talks between WBD and Paramount Skydance hit a standstill. Now, the negotiation table has been dusted off. WBD has reopened discussions and agreed to a seven-day negotiation window.
Market Takeaway: This seven-day period sends a clear message: urgency and seriousness are in the air. Both sides are pushing for answers, and any resulting deal could spark significant changes across the media landscape. While the outcome remains uncertain, these moves are worth close attention.
👀 Levels to Watch:
Upside: Above $28.90
Downside: Below $28.10
Paramount Skydance ($PSKY)
The Scoop: Paramount Skydance is once again in the negotiation room, showing renewed interest that could lead to a major partnership or even an acquisition.
Market Takeaway: Paramount offers a strong portfolio, while Skydance brings technical expertise. A union with WBD could create a content giant. Volatility is likely high throughout this seven-day period, with rapid stock movements expected on any news, official or rumored.
👀 Levels to Watch:
Upside: Above $10.79
Downside: Below $10.25
🏥 The Big Healthcare Buyout: Masimo & Danaher
While media executives talk, healthcare leaders are making moves—big ones.
Masimo ($MASI)
The Scoop: Masimo is set to be acquired by Danaher in a staggering $9.9 billion deal, targeted for completion in the second half of 2026.
Market Takeaway: Masimo, renowned for innovation in noninvasive monitoring, gains a valuation that affirms its industry leadership. Current shareholders are likely thrilled with this exit, which represents both a premium and validation of the company’s tech.
👀 Levels to Watch:
Upside: Above $175.50
Downside: Below $174.26
Danaher ($DHR)
The Scoop: Danaher is strengthening its diagnostics game with the acquisition. The deal is expected to be accretive to adjusted earnings by $0.15 to $0.20 per share in the first full year.
Market Takeaway: Danaher has a proven track record as a smart acquirer, focused on efficiency and synergy rather than growth alone. While acquisitions can sometimes drag on initial stock performance, the long-term outlook appears solid with seamless integration likely ahead.
👀 Levels to Watch:
Upside: Above $212.00
Downside: Below $196.75
Days like these highlight the excitement of the market: the speculative energy of media mergers complemented by the tangible impact of a healthcare buyout. Opportunities abound for those with discipline and a keen eye for trends.
Stay disciplined, keep focused on the key levels, and avoid letting emotions drive trading decisions.
Onward and upward!
The Stock Region Team
Disclaimer: This newsletter is provided for educational and informational purposes only. The information presented here does not constitute a recommendation to buy or sell any specific securities. Trading stocks and options involves a high degree of risk and may not be suitable for all investors. Past performance is not indicative of future results. Always conduct your own due diligence.